Completed Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors NCT04023669 Conditions Brain Cancer, Brain Diseases, Brain Neoplasms, +27 more Locations St. Jude Children's Research Hospital — Memphis, Tennessee, United States View Trial Details
Active, Not Recruiting T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors NCT02442297 Conditions Brain Diseases, Brain Neoplasms, Brain Tumor, Recurrent, +7 more Locations Houston Methodist Hospital — Houston, Texas, United States Texas Children's Hospital — Houston, Texas, United States View Trial Details
